M E O'Brien Selected Research

M E O'Brien Research Topics

4	Breast Neoplasms (Breast Cancer) 06/2011 - 01/2000
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2001 - 10/2000
2	Neoplasms (Cancer) 09/2001 - 01/2000
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 06/2011
1	Carcinoma (Carcinomatosis) 06/2011
1	Postmenopausal Osteoporosis 09/2001
1	Small Cell Carcinoma 01/2001
1	Lung Neoplasms (Lung Cancer) 01/2001
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2000
1	Mesothelioma 10/2000
1	Inflammation 10/2000
1	Disease Progression 06/2000
1	Inflammatory Breast Neoplasms 06/2000
1	Necrosis 01/2000

2	Vinblastine (Vinblastine Sulfate)FDA Link 03/2001 - 01/2001
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 03/2001 - 01/2001
1	subacute Cerebellar degenerationIBA 06/2011
1	Raloxifene (Evista)FDA Link 09/2001
1	Estrogens (Estrogen)FDA Link 09/2001
1	Cisplatin (Platino)FDA LinkGeneric 03/2001
1	Carboplatin (JM8)FDA LinkGeneric 01/2001
1	AntibodiesIBA 12/2000
1	SRL172IBA 10/2000
1	Fluorouracil (Carac)FDA LinkGeneric 06/2000
1	5-ethynyluracil (eniluracil)IBA 06/2000
1	CytotoxinsIBA 06/2000
1	Interleukin-2 (IL2)IBA 01/2000
1	Interleukin-4 (Interleukin 4)IBA 01/2000
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2000
1	Interferon-gamma (Interferon, gamma)IBA 01/2000

6	Drug Therapy (Chemotherapy) 03/2001 - 01/2000
2	Combination Drug Therapy (Combination Chemotherapy) 10/2000 - 06/2000
1	Aftercare (After-Treatment) 09/2001
1	Radiotherapy 01/2001
1	Injections 10/2000
1	Blood Transfusion (Blood Transfusions) 01/2000